These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2537348)

  • 21. Topical mechlorethamine therapy for mycosis fungoides.
    Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
    Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
    Benjamin Chase A; Markel K; Tawa MC
    Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
    Querfeld C; Geskin LJ; Kim EJ; Scarisbrick JJ; Quaglino P; Papadavid E; Angello JT; Ortiz-Romero PL
    J Invest Dermatol; 2021 Jun; 141(6):1601-1604.e2. PubMed ID: 33347924
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical chemotherapy in mycosis fungoides.
    Grupper C; Durepaire R
    Bull Cancer; 1977; 64(2):323-34. PubMed ID: 912134
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
    Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
    Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
    Hamminga B; Noordijk EM; van Vloten WA
    Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients.
    Nielsen M; Rasmussen K; Knudsen N; Thestrup-Pedersen K
    Acta Derm Venereol; 1994 Jan; 74(1):70-1. PubMed ID: 7908491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of teniposide (VM26) in cutaneous T-cell lymphomas.
    Sorio R; Tirelli U; Zagonel V; Carbone A; Monfardini S
    Am J Clin Oncol; 1990 Feb; 13(1):14-6. PubMed ID: 2305716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
    Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients.
    Hamminga L; Hermans J; Noordijk EM; Meijer CJ; Scheffer E; Van Vloten WA
    Br J Dermatol; 1982 Aug; 107(2):145-55. PubMed ID: 6809030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
    Kim EJ; Geskin L; Guitart J; Querfeld C; Girardi M; Musiek A; Mink DR; Williams MJ; Angello JT; Bailey WL
    J Am Acad Dermatol; 2020 Sep; 83(3):928-930. PubMed ID: 32089294
    [No Abstract]   [Full Text] [Related]  

  • 33. Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides.
    Vonderheid EC; Van Scott EJ
    Cleve Clin Q; 1983; 50(2):97-100. PubMed ID: 6640944
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical treatment of early cutaneous T-cell lymphoma.
    Ramsay DL; Meller JA; Zackheim HS
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
    Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
    Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
    Vonderheid EC
    Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
    [No Abstract]   [Full Text] [Related]  

  • 37. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.
    Nguyen CV; Bohjanen KA
    Dermatol Clin; 2015 Oct; 33(4):683-96. PubMed ID: 26433841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
    Laffitte E; Venetz JP; Aubert JD; Duchosal MA; Panizzon RG; Pascual M
    Dermatology; 2008; 217(1):87-8. PubMed ID: 18446031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.